Abstract
Cardiovascular (CV) disease accounts for 30% of all deaths in Canada, and the number of deaths is expected to rise as our population ages.1-3 There is irrefutable evidence demonstrating that controlling modifiable risk factors effectively reduces the risk of CV events and mortality.4-7 Among patients at high risk for CV events, studies in different settings have consistently shown that achievement of evidence-based treatment targets is less than ideal.8-12 Recent Canadian data, however, remain sparse on the topic.13-16 The reason for the gap between research evidence and clinical practice is likely multifactorial. One factor may be that traditionally, only physicians had the privilege to prescribe medications. Pharmacists in Alberta have been able to prescribe since 2007. To our knowledge, however, there is no published information identifying if pharmacists are proactively managing the therapy of Albertans. Given this, the purpose of this pilot study was to assess both the management of modifiable risk factors among patients known to be high risk for CV events and the role of pharmacists in this process of care.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
